Novartis AG
No trades
No trades
Price target
125.280.000.00%
The 23 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 30 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise
This is not investment advice and doesn't take into account your personal circumstances. It isn't a recommendation to buy, sell, or hold any asset. See the Terms of Use and always do your own research.
Frequently asked questions
The current price of NOVN is 126.50 CHF — it has decreased by −0.82% in the past 24 hours. Watch Novartis AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange Novartis AG stocks are traded under the ticker NOVN.
NOVN stock has risen by 3.22% compared to the previous week, the month change is a −0.79% fall, over the last year Novartis AG has showed a 23.58% increase.
We've gathered analysts' opinions on Novartis AG future price: according to them, NOVN price has a max estimate of 140.28 CHF and a min estimate of 93.71 CHF. Watch NOVN chart and read a more detailed Novartis AG stock forecast: see what analysts think of Novartis AG and suggest that you do with its stocks.
NOVN reached its all-time high on Jul 29, 2026 with the price of 131.50 CHF, and its all-time low was 34.40 CHF and was reached on Aug 11, 2011. View more price dynamics on NOVN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NOVN stock is 0.97% volatile and has beta coefficient of 1.17. Track Novartis AG stock price on the chart and check out the list of the most volatile stocks — is Novartis AG there?
Today Novartis AG has the market capitalization of 233.25 B, it has increased by 3.26% over the last week.
Yes, you can track Novartis AG financials in yearly and quarterly reports right on TradingView.
Novartis AG is going to release the next earnings report on Oct 27, 2026. Keep track of upcoming events with our Earnings Calendar.
NOVN earnings for the last quarter are 1.95 CHF per share, whereas the estimation was 1.75 CHF resulting in a 11.17% surprise. The estimated earnings for the next quarter are 1.79 CHF per share. See more details about Novartis AG earnings.
Novartis AG revenue for the last quarter amounts to 11.65 B CHF, despite the estimated figure of 11.38 B CHF. In the next quarter, revenue is expected to reach 11.70 B CHF.
NOVN net income for the last quarter is 2.58 B CHF, while the quarter before that showed 2.47 B CHF of net income which accounts for 0.00% change. Track more Novartis AG financial stats to get the full picture.
Yes, NOVN dividends are paid annually. The last dividend per share was 3.70 CHF. As of today, Dividend Yield (TTM)% is 2.90%. Tracking Novartis AG dividends might help you take more informed decisions.
Novartis AG dividend yield was 3.38% in 2025, and payout ratio reached 61.77%. The year before the numbers were 3.95% and 67.17% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Aug 24, 2026, the company has 75.27 K employees. See our rating of the largest employees — is Novartis AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Novartis AG EBITDA is 16.98 B CHF, and current EBITDA margin is 40.92%. See more stats in Novartis AG financial statements.
Like other stocks, NOVN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Novartis AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Novartis AG technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Novartis AG stock shows the buy signal. See more of Novartis AG technicals for a more comprehensive analysis.